Literature DB >> 26260925

Enhanced molecular mobility of ordinarily structured regions drives polyglutamine disease.

Christopher J Lupton1, David L Steer1, Patrick L Wintrode2, Stephen P Bottomley1, Victoria A Hughes3, Andrew M Ellisdon4.   

Abstract

Polyglutamine expansion is a hallmark of nine neurodegenerative diseases, with protein aggregation intrinsically linked to disease progression. Although polyglutamine expansion accelerates protein aggregation, the misfolding process is frequently instigated by flanking domains. For example, polyglutamine expansion in ataxin-3 allosterically triggers the aggregation of the catalytic Josephin domain. The molecular mechanism that underpins this allosteric aggregation trigger remains to be determined. Here, we establish that polyglutamine expansion increases the molecular mobility of two juxtaposed helices critical to ataxin-3 deubiquitinase activity. Within one of these helices, we identified a highly amyloidogenic sequence motif that instigates aggregation and forms the core of the growing fibril. Critically, by mutating residues within this key region, we decrease local structural fluctuations to slow ataxin-3 aggregation. This provides significant insight, down to the molecular level, into how polyglutamine expansion drives aggregation and explains the positive correlation between polyglutamine tract length, protein aggregation, and disease severity.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Huntington disease; Machado-Joseph disease; amyloid; ataxia; ataxin-3; molecular dynamics; polyglutamine; protein misfolding; spinocerebellar ataxia type-3

Mesh:

Substances:

Year:  2015        PMID: 26260925      PMCID: PMC4591807          DOI: 10.1074/jbc.M115.659532

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Towards the treatment of polyglutamine diseases: the modulatory role of protein context.

Authors:  A L Robertson; S P Bottomley
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

2.  Probing the non-covalent structure of proteins by amide hydrogen exchange and mass spectrometry.

Authors:  D L Smith; Y Deng; Z Zhang
Journal:  J Mass Spectrom       Date:  1997-02       Impact factor: 1.982

3.  Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on ataxin-3 deubiquitinating activity.

Authors:  Stephen D Weeks; Kimberly C Grasty; Lisa Hernandez-Cuebas; Patrick J Loll
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

Review 4.  Opinion: What is the role of protein aggregation in neurodegeneration?

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

5.  The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis.

Authors:  Erica Rockabrand; Natalia Slepko; Antonello Pantalone; Vidya N Nukala; Aleksey Kazantsev; J Lawrence Marsh; Patrick G Sullivan; Joan S Steffan; Stefano L Sensi; Leslie Michels Thompson
Journal:  Hum Mol Genet       Date:  2006-11-29       Impact factor: 6.150

6.  The conformational dynamics of a metastable serpin studied by hydrogen exchange and mass spectrometry.

Authors:  Yuko Tsutsui; Lu Liu; Anne Gershenson; Patrick L Wintrode
Journal:  Biochemistry       Date:  2006-05-30       Impact factor: 3.162

7.  Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.

Authors:  E Scherzinger; R Lurz; M Turmaine; L Mangiarini; B Hollenbach; R Hasenbank; G P Bates; S W Davies; H Lehrach; E E Wanker
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

8.  Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent.

Authors:  Karunakar Kar; Murali Jayaraman; Bankanidhi Sahoo; Ravindra Kodali; Ronald Wetzel
Journal:  Nat Struct Mol Biol       Date:  2011-02-13       Impact factor: 15.369

9.  In-cell aggregation of a polyglutamine-containing chimera is a multistep process initiated by the flanking sequence.

Authors:  Zoya Ignatova; Ashwani K Thakur; Ronald Wetzel; Lila M Gierasch
Journal:  J Biol Chem       Date:  2007-10-17       Impact factor: 5.157

10.  The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition.

Authors:  Giuseppe Nicastro; Rajesh P Menon; Laura Masino; Philip P Knowles; Neil Q McDonald; Annalisa Pastore
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

View more
  8 in total

1.  Amyloid cores in prion domains: Key regulators for prion conformational conversion.

Authors:  María Rosario Fernández; Cristina Batlle; Marcos Gil-García; Salvador Ventura
Journal:  Prion       Date:  2017-01-02       Impact factor: 3.931

2.  A Robust Assay to Monitor Ataxin-3 Amyloid Fibril Assembly.

Authors:  Francisco Figueiredo; Mónica Lopes-Marques; Bruno Almeida; Nena Matscheko; Pedro M Martins; Alexandra Silva; Sandra Macedo-Ribeiro
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

3.  Thermodynamic and kinetic stability of the Josephin Domain closed arrangement: evidences from replica exchange molecular dynamics.

Authors:  Gianvito Grasso; Jack A Tuszynski; Umberto Morbiducci; Ginevra Licandro; Andrea Danani; Marco A Deriu
Journal:  Biol Direct       Date:  2017-01-19       Impact factor: 4.540

Review 4.  Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch.

Authors:  E F E Kuiper; Eduardo P de Mattos; Laura B Jardim; Harm H Kampinga; Steven Bergink
Journal:  Front Neurosci       Date:  2017-03-23       Impact factor: 4.677

5.  Identification of a novel site of interaction between ataxin-3 and the amyloid aggregation inhibitor polyglutamine binding peptide 1.

Authors:  Patrick D Knight; Theodoros K Karamanos; Sheena E Radford; Alison E Ashcroft
Journal:  Eur J Mass Spectrom (Chichester)       Date:  2017-08-29       Impact factor: 1.067

6.  Protein Environment: A Crucial Triggering Factor in Josephin Domain Aggregation: The Role of 2,2,2-Trifluoroethanol.

Authors:  Cristina Visentin; Susanna Navarro; Gianvito Grasso; Maria Elena Regonesi; Marco Agostino Deriu; Paolo Tortora; Salvador Ventura
Journal:  Int J Mol Sci       Date:  2018-07-24       Impact factor: 5.923

Review 7.  Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms.

Authors:  Sofia Giorgetti; Claudio Greco; Paolo Tortora; Francesco Antonio Aprile
Journal:  Int J Mol Sci       Date:  2018-09-09       Impact factor: 5.923

Review 8.  Using protein engineering to understand and modulate aggregation.

Authors:  Jessica S Ebo; Nicolas Guthertz; Sheena E Radford; David J Brockwell
Journal:  Curr Opin Struct Biol       Date:  2020-02-19       Impact factor: 6.809

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.